A Texas woman has filed a lawsuit in the federal court of the Eastern District of New York against the makers of Xarelto, a new class of blood thinner. In it, she alleges that she sustained serious injuries, signs of internal bleeding due to the company’s failure to warn her about the potential risks of using the drug and that the company failed to conduct safety testing that was sufficient before placing the blood thinner on the market. Her lawsuit is similar to many others filed against Janssen and Bayer AG. The case is listed under the federal court docket number 1:14-CV-04524 and is available in its entirety to read below.
December 7, 2015 – BloodThinnerHelp.com reports that a Texas woman has filed a lawsuit in the Eastern District of New York alleging that Janssen Pharmaceuticals and Bayer AG, the manufacturers of Xarelto, failed to provide sufficient warnings to consumers about the potential risk of the signs of internal bleeding with this blood thinner. In federal court, the latest complaint was filed under 1:14-CV-04524.
The lawsuit contains details about how the drug was prescribed to treat a condition known as atrial fibrillation. This condition can cause strokes due to blood clots. As a preventative measure, cases of this type are commonly treated with blood thinners. However, just five months after taking the blood thinner, she experienced an internal bleed that was life threatening. While the complaint does not specify much of the details of the injury, it does state that specialized care will be required due to long tern health effects that occurred as a consequence of the bleed.
After the U.S. Food and Drug Administration approved Xarelto in 2011, it was released to the market for prescription. Initially, the new drug was regarded as an option that was revolutionary, because it did not require a special diet, adjustments by physicians, or regular monitoring. However, once consumers realized that there was no antidote, this early excitement was short lived. Currently, it is seen by many to be the market’s most dangerous blood thinner.
Because there is no antidote, if a patient taking Xarelto begins to show the signs of internal bleeding after an injury, there is no way to get the blood to clot by countering the effects of the drug. In order to keep the patient alive when this happens, blood transfusions and other extreme measures to save their life must be used. In addition, operations are sometimes necessary when pools of blood develop in the spine or brain in order to relieve the built up pressure in the body by draining the blood.
Vitamin K provides an antidote for traditional blood thinners. Because of this, the effects of the traditional blood thinner are counteracted and blood clots can form when an injury occurs. It is the difference between living and dying in these cases.
Federally, there have been about 2,000 cases filed against Xarelto for bleeding that cannot be controlled. In the Eastern District of Louisiana, the Honorable Judge Eldon Fallon is overseeing the consolidation of these cases in Multidistrict litigation number 2To 592. Attorney Joseph Osborne is working to make sure that everyone has the opportunity to evaluate their legal rights if they were affected by Xarelto as these cases are prepared for trial. There may be a significant compensation for individuals who suffered adverse health effects and any signs of internal bleeding due to using Xarelto. To those involved, free legal consultations are available from attorney Osborne.
Please contact our attorney today for additional information or to ask questions about the Xarelto bleeding lawsuits.
Xarelo is a new Novel Oral Anticoagulant category (NOAC) blood-thinner medication manufactured by Johnson & Johnson and Bayer AG. It is used for treating several different conditions, including deep vein thrombosis, pulmonary embolism and atrial fibrillation. However, Xarelto is considered to be a high-risk medication and ruled responsible for serious injuries like liver damage symptoms and the deaths of several patients. Hundreds of lawsuits have been filed against the manufacturers of the drug as a result of so many individuals suffering uncontrollable internal bleeding to the point that even after being hospitalized doctors still had no way of stopping it. Unlike other similar drugs like Warfarin, there is no known antidote for reversing the effects of Xarelto, so once life-threatening bleeding takes place; the patient is at risk of death or severe injuries.
However, there are also several other potentially very serious or fatal side effects for Xarelto that are still under post-marketing investigation currently since the drug was introduced in 2008 to the worldwide market. Risk of liver damage is one of the more alarming adverse reactions that is associated with the drug Xarelto. Liver damage symptoms caused by Xarelto have been investigated for being a potential risk for individuals taking Xarelto medication. There have also been several Xarelto-induced liver injury cases that have been reported. These include several cases of acute liver failure. The results from three big international pharmacovigilance databases were recently analyzed. The analysis revealed that Xarelto was suspected to be a cause in a large number of hepatic adverse cases.
In addition to gastrointestinal bleeding and internal hemorrhage, liver damage symptoms are the most reported Xarelto side effect. It can be discovered in blood tests by elevated enzymes AST and ALT. The 4 Record study results showed that of the 6,183 patients that were treated with rivaroxaban, 2.33% had increased liver enzyme (transaminase) levels that were over 3 times higher than ULN (upper limit of normal). There were two other cases where patient showed liver damage symptoms after being treated with Xarelto which were published recently in the Journal of American Medical Association, which further confirms this drug’s alarming potential hepatotoxicity.
Another thing that should be noted is that more than two-thirds of the drug, which is administered orally, is eliminated via urine or bile following hepatic metabolism. If liver function has been comprised, the blood levels of the drug may potentially increase due to the liver being unable to eliminate a sufficient quantity of Xarelto out of the body. However, this medication’s main selling points were the fact that blood monitoring was not required and its purported safety. These points were advertised widely over the internet and television.
Without any blood monitoring, it results in patient not being aware if the effects from the drug have increased to the level of growing potentially dangerous due to an increased risk for bleeding accidents. Therefore, this requires that an appropriate adjustment to the dosage be made.
Since being treated with Xarelto can potentially be associated with symptomatic and severe liver damage symptoms and consequently bleeding risk, the physician and patient both need to be fully informed about this potentially significant danger. The drug label should include a warning about the potential symptomatic liver damage; otherwise patients who suffer liver injury as a Xarelto side effect have the right to file a lawsuit in reference to misleading information being provided by the manufacturers.
There are a number of side effects associated, and one of the most dangerous is internal bleeding signs, which can lead to death. People have filed lawsuits against Bayer as a result of internal bleeding. They filed lawsuits claiming Bayer did not warn of internal bleeding.
Bayer Healthcare, as well as Johnson & Johnson’s Janssen subsidiary has been hit with a number of product liability lawsuits. The lawsuits have been filed on behalf of people from all around the country. These people have suffered from internal bleeding signs and severe bleeding injuries as a result of Xarelto.
The date for the trials have been set, and the truth is that litigation against Xarelto just keeps on growing because new lawsuits are filed daily, and one of the most recent ones come from a woman in Florida. She claims the medicine caused her husband to die because it leads to fatal internal bleeding signs. The litigation is still in the stages of pretrial, and the dates have already been pushed a number of times, but this time around there are dates for the first two trials, with one being on February 6, 2017 and the other being on March 13, 2017.
The third trial is going to be held in Mississippi on April 24, 2017, and it will also be held on May 30, 2017 in the state of Texas and only these four cases will be heard during the bellwether trials and this is because of the number of lawsuits that have been filed. You may be wondering why these four cases have been chosen and there is a reason for this. The lawsuits were chosen because they are considered to be the most representative cases.
In Xarelto MDL, the defendants will be the manufacturers of Xarelto, which is Janssen Pharmaceuticals, and Bayer AG, and the plaintiffs are accusing the companies of negligence because they are accused of not properly warning people about the dangers of the medicine. The medicine’s side effects don’t include internal bleeding signs episodes that may lead to a person dying and there is nothing on the market that can reverse the medicine’s side effects, and the plaintiffs are accusing the companies of knowing this, yet they still chose to market the medicine and advertise it as a safer drug to use then their competitors’ drugs.
In December 2014 was when MDL was consolidated and since then, there have been a number of lawsuits filed and some of the damages include pain and suffering, as well as loss of wages, medical treatment and even funeral costs. If you have ever taken the medicine or someone you know has, and you or they have experienced internal bleeding signs, then you should speak with an advocate as soon as possible, as they will be able to answer some questions for you. Keep in mind the amount of money you can recover via a lawsuit does depend on a number of factors, such as age, the extent of the injury and whether or not the person died and whether or not the patient had any dependents.
Have you taken Xarelto and now you are wondering if you have suffered any side effects from it? Maybe you are wondering what the side effects of Xarelto are. If you are curious about the side effects of xarelto, then continue to read the rest of this article, as some of the side effects will be discussed below.
There are quite a few common side effects associated with Xarelto, and this includes pain in the back, bleeding gums, as well as blood in your stool. The pain in your back could vary in pain, and so can the amount of blood in your stool. Asides from those three side effects, other common ones include bowel or bladder dysfunction, as well as tingling feelings or the feeling of pins and needles. You might also experience some itching or burning.
Those who cough off blood or have a hard time breathing or swallowing may be doing so because of using Xarelto. The drug can also cause you to have a headache and you might feel dizzy, as this is another side effect associated with the drug. Another common side effect that some users may experience is weakness in one or both of their legs.
Nosebleeds, prolonged bleeding from cuts and numbness are other common side effects associated with Xarelto. Not only that, but other common ones include stools that are tarry and are red or black. If your urine is red or dark brown, then it may be because you are using Xarelto, and if you are a woman, then you may experience an increased menstrual flow.
There are even more common side effects that the drug has. One of the most serious and common ones is throwing up blood. Sometimes you might vomit material that resembles coffee grounds, and you might experience paralysis.
Xarelto can cause less common side effects, which includes fainting. Not everyone will experience this side effect, but some people may. Feeling pain in your arms or legs, as well as wound secretion are other less common side effects of xarelto.
Asides from the common and less common side effects, there are a few rare ones that some users may encounter. One of the most rarest ones is burning while urinating. As for how much it will burn, that depends, but generally speaking, a burning sensation may be felt by some users of Xarelto
Another rare one is having a very hard time urinating. You may feel like you have to urinate, but you may find it difficult to do. Asides from being difficult, you might even find it painful to urinate.
If you experience those side effects, and you are taking Xarelto, then you should contact your doctor. The side effects may be the result of using the drug. Even if they are not, it is still a good idea to have a doctor look at you.
There are some side effects of xarelto which are not really familiar, therefore it is not really proven that some unknown incidents are a result of using Xarelto. With that said, it is possible that some other side effects associated with Xarelto are pain in the stomach region, as well as swelling and your vision may become blurred or your skin could blister up or peel. Very dark urine is another potential side effect, but unproven one.
There are two more side effects that could potentially be linked to Xarelto and this includes blisters. If you take the drug and notice that blisters have appeared, then this may very well be because of Xarelto. Muscle spasms may also be experienced by Xarelto users, and if you do experience such symptoms, then you might want to consider getting medical attention because it may or may not be the results of using Xarelto.
As you can see, there are a lot of different side effects of Xarelto. If you suspect that you have suffered from any of the above side effects, then you should visit your doctor as soon as possible. They will be able to examine you, speak with you and determine whether or not Xarelto resulted in side effects.
Xarleto lawsuit is one of the latest class action cases that are likely to be filed against a pharmaceutical company. It looks like pharmaceutical companies are not anywhere close to carefully checking their products before they roll them over to you. Once again, there is a new class action lawsuit in town. The tendency for the pharmaceutical companies is to focus on profits alone while ignoring the welfare of the end user has come to the fore. You could be a victim so know the things beforehand about the join class action lawsuits of Xarelto.
Xarleto is a blood thinning agent and is commonly prescribed for patients with atrial fibrillation; also referred to, commonly, as irregular heart beat condition. The drug, technically referred to as an anti coagulant is also used to prevent Deep Vein Thrombosis often denoted as DVT. Knee and hip replacement surgeons also recommend the drug to manage blood clots associated with the operation.
Xarleto is manufactured by the giant German pharmaceutical company; Bayer. In the United States, the drug is marketed by Johnson and Johnson. According to the figures released by the manufacturer, about 7 million people have used xarleto. What the legal fraternity has a keen eye on is the process of the introduction of the drug in the United States and the subsequent fast approval for its use. The speed at which the procedure led to approval raises eyebrows as has happened in the past. It seems as if the need to make more money clouded the proponents of the drug, including the FDA, to avail the drug to the public before it was sufficiently tested and found safe for use by the innocent public. You must join class action lawsuits of xarelto lawyers with the good intent of stopping this heinous trend of pharmaceutical companies putting financial gain before safety. If we don’t act in solidarity, we shall remain victims.
The main concern here is that xarleto has been seen to work well, I mean rather too well. It is true that xarleto effectively succeeds in thinning blood and consequently prevents clotting. Tests show that xarleto exceeds the limit because in the end your blood is thinned beyond safety. So, you must be wondering what the hullaballoo is about! Well, xarleto solves one problem and creates another one. The concern is that the problem created by xarleto could be more dangerous that the problem it tries to solve. Since xarleto makes your blood too thin, it then means that you stand a chance of bleeding profusely. If you are not anywhere near a medical facility, it means your life is at potential risk; you could die of bleeding. Your blood has been deprived of its natural clotting mechanism and will ooze out like a jet in greater volume because it is thinner than normal; thanks to xarleto.
Although there has been a need to develop drugs to mitigate patient conditions, including a need for blood thinning drugs, it is important that enough research is invested in a drug before it is applied in treatment. There are similar drugs that are on the market but have not drawn this negative publicity. One such example is Warfarin. The drug has been around for decades. Although, like many other drugs, Warfarin has its side effects, there was enough research, actually 60 years research, on it before it was released to the public. Xarleto on the other hand has an extremely short history. It was literally rushed to the consumer market. Furthermore, apart from the risk it clearly poses to life, it does not have its antidote pair that can slow or stop bleeding.
The big question that begs is; would anyone willingly accept to use a drug that poses a risk of
• Heart failure?
• Bleeding to death?
• Organ failure?
• Pulmonary embolism?
• Brain haemorrhage?
• Gastro intestinal bleeding?
Furthermore, would you knowingly use xarleto if you were told it has no antidote to reverse profuse bleeding?
If you have taken xarleto, or anyone in your family, friends accomplices; basically, anyone you know, you need to call your lawyer or contact our attorney so that you can begin a journey to join class action lawsuits of xarelto demanding for justice. Did you know that despite the risk the drug poses, you spend $3000 every year as compared to only $300 that other blood thinners cost? You need to join the Xarleto lawsuit.
Xarelto is a blood thinning medication that is often prescribed since it was believed to be an efficient way to treat and prevent blood clots. Xarelto is also known as Rivaroxaban and comes in 10, 15 or 20 milligrams tablets. If you are prescribed Xarelto or a relative took this medication, you should be able to obtain compensation through the class action settlements since this medication was found to lead to serious health complications.
Xarelto was typically prescribed to patients who had a high risk of forming blood clots due to irregular heartbeat, a condition known as atrial fibrillation. A lot of patients who underwent hip or knee replacement surgery were prescribed this medication to prevent blood clots from forming in the hip or knee area as a result of the surgery. Xarelto was also prescribed to treat conditions such as pulmonary embolism.
This medication works by changing the way blood coagulates. This is a good way to prevent blood clots from appearing for patients who are at risk for this health issue but taking Xarelto can lead to some serious complications since this medication can cause uncontrolled bleeding.
There are some serious side effects associated with taking Xarelto. These side effects include frequent nose bleeds, swelling, fatigue, heavy and prolonged menstrual flows, heavy bleeding when a cut occurs, bleeding of the gums, bruising, difficulty swallowing and finding blood in one’s vomit, urine or stools. Severe allergic reactions can also occur, which are typically characterized by swelling, chest tightness and a rash.
Xarelto is dangerous because it prevents blood from coagulating. This means a patient can lose enough blood to be in a life-threatening condition if an injury occurs near an organ. Because the blood cannot coagulate, pools of blood can accumulate inside of the patient’s system and lead to other complications, including liver damage. And since blood cannot coagulate, severe bleeding can lead to blood flow being completely cut from an organ. An important organ like the brain, the heart or the lungs can lose some of its ability to properly function if blood flow is cut for too long.
More importantly, this uncontrollable bleeding can result in death if the patient does not have access to an emergency room. This is why taking Xarelto is dangerous and a class action lawsuit has been filed so that patients who took the medication or people who lost a loved one due to the dangerous side effects of this drug can receive class action settlements.
A class action lawsuit is filed when a large number of individual lawsuits against the same entity exist and have been filed for the same reason. Class action lawsuits are usually filed in situations where a large number of people qualify for class action settlements but processing individual lawsuits would be time-consuming and expensive. There are more than 1,600 different lawsuits filed against the company that distributed Xarelto, and these lawsuits have been consolidated into one large class action lawsuit in Louisiana. There is also another class action lawsuit filed against this company in Canada.
You can take part in this class action lawsuit if you were prescribed this drug or if a loved one took it.
Joining the patients and families of patients who took this medication in the class action settlements means you will receive compensation if the Louisiana court rules that the drug company behind Xarelto failed to properly warn patients against the risks associated with taking this blood thinner. And given the high number of individuals lawsuits that were filed and the terrifying implications of the side effects that resulted from taking this drug, it seems very likely that plaintiffs would be granted compensation once all the evidence is reviews by the court.
Taking part in a class action lawsuit means you no longer have the right to file an individual lawsuit for the same complaint. However, you will not have to pay any attorney fees and will not have to go through the entire filing process since the lawsuit has already been filed. You should definitely consider taking part in the class action settlements if you took the medication, especially if you suffered from any of the side effects or lost a loved one.
Xarelto is Bayer’s multi billion dollar blood thinner marketed to prevent stroke and internal blood cuts. It might be a bestseller in the healthcare arena, but Xarelto adverse effects including unstoppable internal bleeding that may lead to death. For this and the lack of public warning, Bayer faces lawsuits filed by Xarelto victims.
Xarelto’s active ingredient is rivaroxaban (pronounced, Riv a Rox a ban). The drug is also composed of other inactive ingredients including hypromellose, lactose monohydrate, magnesium stearate, croscarmellose sodium, sodium lauryl sulfate and microcrystalline cellulose. So far, there is no generic form of this drug sold in the U.S market.
Xarelto is generally used to treat deep vein thrombosis, a serious blood clotting condition which could potentially lead to pulmonary embolism or the sudden blockage of major blood arteries in the lungs. Xarelto is also used for patients who have heart rhythm disorders to lower the risk of stroke which is caused by blood clotting.
Unfortunately, the likelihood of severe hemorrhage as a side effect from taking Xarelto is common. Hemorrhage is not just the common Xarelto adverse effects as liver dysfunction and abnormal blood clotting in organs were also cited by clinical studies on patients who used the drug. Xarelto can also be associated with indigestion, muscle spams, backache, urinary tract infection and abdominal pain. Studies also cited that Xarelto has some rare side effects including giant hives, hepatitis, abdominal bleeding and Steven-Johnson syndrome.
Despite the challenges of the FDA against Johnson and Johnson, the manufacturer still continues to promote the drug as safe and effective. J&J’s request for the FDA to approve Xarelto’s expanded uses have been declined three times.
Johnson & Johnsons wants to promote the drug for treating a certain condition based on a clinical conclusion from a study called ANCHOR. This specific usage might still be unapproved, but the company stated that doctors are already using it for cases associated with that study.
Xarelto belongs to a drug class known as Factor Xa inhibitors. Its side effects heighten if the drug is taken with other anticoagulant drugs. It is very necessary to talk to your doctor before using Xarelto and it shouldn’t be self-administered. Before using the drug, inform your doctor if you have; kidney or liver problem, another medical condition, has bleeding problems or is pregnant or wanting to become pregnant.
If you or a loved one suffered from the dangerous adverse effect of Xarelto, you can file a case against the manufacturer. A financial settlement may be made between the victim and J&J. You can file damages for reimbursements, for emotional trouble, medical expenses, lost wages and other burden results from Xarelto adverse effects.
As of the first half of 2015, there are already 2000 cases involved in Xarelto litigation.
On the 2014’s PmLiVE Top Pharma List, Xarelto ranked as 23rd of the top 50 pharmaceutical products by global sales ranking. This ranking translates into big revenue for Bayer and Johnson & Johnson, the makers of the drug, both healthcare giants.
• Reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). There are limited data on the relative effectiveness of XARELTO® (rivaroxaban) and warfarin in reducing the risk of stroke and systemic embolism when warfarin therapy is well controlled. Treatment of deep vein thrombosis (DVT). Treatment of pulmonary embolism (PE). Reduction in the risk of recurrence of DVT and of PE following initial 6 months treatment for DVT and/or PE
• Xarelto is sometimes given to patients who went through total hip or total knee arhtroplasty to prevent pulmonary embolism or deep-vein thrombosis.
• Many hospitals trust that rivaroxaban is a better alternative than low-molecular-weight heparin for thromboprophylaxis in lower limb arthroplasty. But in a study, there were fewer wound complications in low-molecular-weight heparin group compared to rivaroxaban.
There have been a number of adverse effects noted from using Xarelto. These include wound complications and infections. Wound complications associated with Xarelto’ usage for total hip or knee arthroplasty may include; infection, leakage, hematoma, chronic pain and prolonged drainage. Several studies support that these side effects likely happen.
During 2015’s Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS), complications associated with using Xarelto were discussed. A study called Rivaroxaban Use for Thrombosis Prophylaxis is an Independent Risk Factor for Early Periprosthetic Joint Infections was presented; citing the significant higher incidence of deep surgical infection in patients treated with Xarelto. At the same conference, physician Dr. Robert L. Barrack of Washington University School of Medicine presented a review called “Aspirin and Mechanical Compression Sleeves are Best for Most.” to where he cited that prescribing aspirin and mechanical compression to patient should suffice for thromboprophylaxis. Dr. Barrack’s presentation created a debate whether the use of anticoagulant such as Xarelto is necessary of patients after surgery.
Xarelto is a blockbuster and is still a front liner in the blood thinner market with sales exceeding $1 billion. Furthermore, the manufacturers Johnson & Johnson’s and Bayer, announced that they are beginning the studies to find more uses of Xarelto. The manufacturers have already proposed a few extended uses of the drug but the FDA declined these.
Ellen Relkin, Weitz & Luxenberg law firm cited that Xarelto presents 10-fold risk to patients using it. She said at that in a presentation at the American Academy of Orthopedic Surgeons, it was concluded that patients taking Xarelto experienced increased of deep surgical infection.
Now cases against Bayer and Johnson & Johnson’s are flooding across different states in the U.S. Thousands of complaints against both manufacturers are expected to arise soon as more patients come to realize the fatal adverse effects of Xarelto
A pretrial procedures move ahead in condition and federal courts for Xarelto complaints, Xarelto bleeding legal cases continue being filed within the blood thinner medication and showing anyone injuries lawsuit that was recently filed concerning a California woman who died after having suffered from the brain bleed apparently consequently of utilizing Xarelto. The complaint stated the woman was recommended Xarelto in August 2012 to deal with atrial fibrillation as well as in august 2014; she possessed a hemorrhagic bleeding around the brain and died consequently. The Xarelto bleeding lawsuit accuses Xarelto manufacturer, Bayer Health care, and Janssen Pharmaceutical drugs Corporation., a subsidiary of Johnson & Johnson, of neglecting to warn doctors as well as their patients concerning the blood thinner side effects which Xarelto doesn’t have an antidote to turn back medication’s effects. The suit was filed in January 15 within the U.S. District Court, Southern District of California.
Xarelto lawyers keep contacting the males and females across the nation who thinks that they’ve encountered bleeding side-effects because of the prescription blood thinner Xarelto. Our attorneys offers free legal consultation services to the people who think they’ve encountered unmanageable bleeding, hemorrhaging along with other side-effect consequences of utilizing Xarelto along with other prescription blood thinner side effects.
Xarelto (rivaroxaban) was authorized by the U.S. Food & Drug Administration (Food and drug administration) to stop deep vein thrombosis, lung embolism and also to prevent stroke in the people who have atrial fibrillation. The oral anticoagulant is recognized as the latest generation blood thinner when in comparison to warfarin, a blood thinner authorized by the Food and drug administration in 1954. Until the invention of the modern blood thinners like Xarelto, Pradaxa and Eliquis received Food and drug administration approval, warfarin have been the only Food and drug administration-approved blood thinner available on the market utilized to stop strokes in patients with atrial fibrillation. Based on the Food and drug administration, warfarin should be carefully supervised with periodic blood tests, but the modern anticoagulants don’t need the periodic bloods test monitoring. The newest blood thinners, however, may cause bleeding and you will find no antidotes to stop the blood thinner side effects, the fedaral agency stated. Warfarin uses vitamin k supplement as a remedy to stop the results Brain Bleeding.
The court records suggest that Xarelto bleeding legal cases that claim the blood thinner causes unmanageable internal bleeding along with other blood thinner side effects are consolidated in the Philadelphia Court of Common Pleas. Administrative Judge Kevin Dougherty produced a mass of tort in January for those Xarelto legal cases that filed in the states of Pennsylvania. Judge Dougherty released a Case Management Order in January that granted a plaintiff’s request to centralize all Xarelto legal cases within the court’s Complex Lawsuit Center for coordinated pretrial proceedings. Judge Dougherty then relocated 75 Xarelto cases in to the lawsuit program at that time he released his order in january 20. Even there are more 97 Xarelto bleeding complaints pending by Feb 9.
For many years now, blood thinner drugs like Pradaxa and Xarelto are related to serious bleeding issues like gastrointestinal bleeding, most of which have induced hospitalizations even also death. The courts have been completely busy in handling Xarelto legal cases filed by victim litigants who claim producers overstated the advantages of these medicines while downplaying the intense unwanted side effects.
Both Pradaxa and Xarelto were promoted to be simpler alternatives to warfarin, the key blood thinner for many years, simply because they allegedly labored just like effectively in lessening stroke along with other perils of thrombus, but needed no bloodstream monitoring or dietary modifications. New research, however, indicates these modern drugs might be more harmful than older ones-directly contradicting the manufacturers’ messages concerning the items.
On April 24, 2015, the British Medical Journal published new research by experts from Johns Hopkins Bloomberg School of Public Health, George Washington College, and Johns Hopkins Medicine in Baltimore.
Experts examined a sizable administrative database of in a commercial sense insured the people of U.S. from October 1, 2010 through March 31, 2012. They were searching for the people who had a doctor’s prescription for warfarin, dabigatran (Pradaxa), or rivaroxaban (Xarelto) and who are 18 years or older. Ultimately, in the final analysis sample of 46,163 patients, 4,907 were on Pradaxa, 1,649 were on Xarelto, and 39,607 were on warfarin.” (The low number for Xarelto was likely since the drug wasn’t Food and drug administration-approved until 2011.)
Effects demonstrated the following:
Experts came to the conclusion: “Although rates of intestinal bleeding appear to become similar from the commercial perspective insured sample of older people in the United States, we can’t eliminate over a 50% rise in the chance of gastrointestinal bleeding with dabigatran in comparison with warfarin or even a greater than twofold higher possibility of bleeding with rivaroxaban in comparison to warfarin.”
This isn’t the very 1st time experts have recommended that Xarelto can lead to more gastrointestinal will bleed. In the year 2012, a brand new analysis of information from among the early clinical tests around the drug (ROCKET-AF) also discovered that chance of intestinal gastrointestinal bleeding issues happened more often in patients having rivaroxaban than warfarin.
A 2013 research identified similar results, confirming that in the an analysis of randomized controlled tests, patients having “newer” oral anticoagulants like Pradaxa and Xarelto were more in danger of gastrointestinal bleeding than patients on standard care.
Litigants who’ve filed Xarelto lawsuits claim the manufacturers should have warned patients and doctors about these severe risks, and also carried out more research on the drug to be certain the once-a-day convenient dosing was truly recommended for everybody.
So for the people who think they may have a prospective claim, it is essential to review your case with an attorney immediately, as a Xarelto time limit will set the time period as well as the compensation. So to learn further info regarding this issue, contact us today.